Literature DB >> 8424842

Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy.

R L Savage1, P W Moller, C L Ballantyne, J E Wells.   

Abstract

OBJECTIVE: To assess the risk of perforation or hemorrhage of peptic ulcer on treatment with nonsteroidal antiinflammatory drugs (NSAIDs), both as a class and as individual agents.
METHODS: A case-control study of medication histories in 494 patients and 972 matched control subjects.
RESULTS: The increase in risk (odds ratio) with NSAID therapy was 5.1 times the risk in controls. The odds ratio for piroxicam was 6.3 (95% confidence interval [CI] 3.3-12.0), as compared with 2.9 for diclofenac, ketoprofen, and sulindac combined (95% CI 2.0-4.2). The effect of other risk factors was also considered, and the adjusted odds ratios were 4.1 for all NSAIDs, 6.4 (95% CI 2.8-15.0) for piroxicam, and 3.3 (95% CI 2.0-5.5) for diclofenac, ketoprofen, and sulindac combined.
CONCLUSION: The estimate of overall risk of peptic ulcer complications with NSAIDs is similar to that found in other studies. There appear to be differences in risk between agents.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8424842     DOI: 10.1002/art.1780360114

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  26 in total

1.  Comparison of tissue concentrations after intramuscular and topical administration of ketoprofen.

Authors:  I Tegeder; J Lötsch; M Kinzig-Schippers; F Sörgel; G R Kelm; S T Meller; G Geisslinger
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

Review 2.  Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly?

Authors:  Ruth Savage
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  A reader's guide to the evaluation of causation.

Authors:  T Podrebarac; P Tugwell; P C Hébert
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401

Review 4.  Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs.

Authors:  J Y Jouzeau; B Terlain; A Abid; E Nédélec; P Netter
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

Review 5.  Preclinical and clinical development of dexketoprofen.

Authors:  D Mauleón; R Artigas; M L García; G Carganico
Journal:  Drugs       Date:  1996       Impact factor: 9.546

6.  Nabumetone in elderly patients with osteoarthritis: economic benefits versus ibuprofen alone or ibuprofen plus misoprostol.

Authors:  J D Bentkover; A M Baker; H Kaplan
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

7.  Arthrotec for all?

Authors:  D Cullen; C J Hawkey
Journal:  Ann Rheum Dis       Date:  1993-12       Impact factor: 19.103

8.  Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data.

Authors:  S C Lewis; M J S Langman; Joan-Ramon Laporte; John N S Matthews; Michael D Rawlins; Bengt-Erik Wiholm
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

9.  Hepatotoxic interaction of sulindac with lipopolysaccharide: role of the hemostatic system.

Authors:  Wei Zou; Sachin S Devi; Erica Sparkenbaugh; Husam S Younis; Robert A Roth; Patricia E Ganey
Journal:  Toxicol Sci       Date:  2008-12-12       Impact factor: 4.849

Review 10.  Bleeding peptic ulcer in the elderly: risk factors and prevention strategies.

Authors:  Angelo Zullo; Cesare Hassan; Salvatore M A Campo; Sergio Morini
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.